Showing results (91-100 of 175) with videos related to

Sort By:
Pageof 18
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 2, 2024
Peptide Receptor Radionuclide Therapy Is Effective for Clinical Control of Symptomatic Metastatic Insulinoma: A Long-Term Retrospective AnalysisLiene Friebe, Martin T Freitag, Martin Braun, et al.
Endocrine|October 1, 2016
10-year follow-up study comparing primary medical vs. surgical therapy in women with prolactinomasLukas Andereggen, Janine Frey, Robert H Andres, et al.
European Heart Journal|May 21, 2024
Risk of heart failure in inflammatory bowel disease: a Swedish population-based studyJiangwei Sun, Jialu Yao, Ola Olén, et al.
JHEP Reports : Innovation in Hepatology|May 9, 2025
Thyroid dysfunction in MASLD: Results of a nationwide studyShuai Yuan, Fahim Ebrahimi, David Bergman, et al.
Acta Cytologica|May 5, 2022
Effects of Rapid On-Site Evaluation on Diagnostic Accuracy of Thyroid Fine-Needle AspirationCelia Fawcett, Serenella Eppenberger-Castori, Stefan Zechmann, et al.
Endocrine Connections|May 3, 2019
Effects of interleukin-1 antagonism on cortisol levels in individuals with obesity: a randomized clinical trialFahim Ebrahimi, Sandrine A Urwyler, Philipp Schuetz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 22, 2024
Risk of major adverse liver outcomes among first-degree relatives of individuals with MASLDWen Yang, Fahim Ebrahimi, Stefano Romeo, et al.
Hypertension (Dallas, Tex. : 1979)|April 11, 2020
IL (Interleukin)-1 Receptor Antagonist Increases Ang (Angiotensin [1-7]) and Decreases Blood Pressure in Obese IndividualsSandrine Andrea Urwyler, Fahim Ebrahimi, Thilo Burkard, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|August 22, 2024
Diverticular disease and risk of incident major adverse cardiovascular events: A nationwide matched cohort studyAnders Forss, Wenjie Ma, Marcus Thuresson, et al.
Pageof 18